Connect with us

What Trump’s reclassification of pot and CBD could mean for seniors, research and stocks

Reclassification to a Schedule III drug and possible Medicare coverage for pot could unlock new investment from pharmaceutical companies.Read More


Discover more from The Who Dat Daily

Subscribe to get the latest posts sent to your email.

More in Financial News